ATAI - CIK 0001840904
The table below shows ATAI Life Sciences N.V.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.40M | $61.94M | $48.29M | $29.96M | $19.33M | $18.87M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $130.67M |
| $102.68M |
| $115.98M |
| $114.07M |
| $117.91M |
| $117.50M |
| Property, plant & equipment | $3.01M | $2.90M | $2.68M | $865.00K | $873.00K | $920.00K |
| Goodwill | $331.00K | $331.00K | $331.00K | - | - | - |
| Total assets | $239.82M | $189.20M | $195.78M | $197.52M | $215.78M | $269.12M |
| Accounts payable | $5.37M | $4.04M | $2.71M | $4.88M | $3.81M | $3.84M |
| Total current liabilities | $16.54M | $25.55M | $28.50M | $19.64M | $17.64M | $15.01M |
| Long-term debt | $0.00 | $0.00 | $9.30M | $20.34M | $15.24M | $15.14M |
| Total liabilities | $79.91M | $45.28M | $43.51M | $51.20M | $47.24M | $45.86M |
| Retained earnings | -$815.44M | -$754.37M | -$726.64M | -$661.25M | -$634.96M | -$577.65M |
| Total equity | $159.75M | $143.74M | $152.05M | $145.72M | $167.89M | $222.54M |